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U.S.-Citizen International Medical Graduates
To the Editor: The Perspective article on U.S.-
citizen international medical graduates (IMGs) 
by Eckhert and van Zanten (April 30 issue)1 used 
data from the National Resident Matching Pro-
gram (NRMP)2 to assert that “the forecasts that 
there would soon be no room in U.S. residency 
programs for IMGs were not accurate: since the 
number of positions for postgraduate-year-1 
[PGY-1] residents increased by 26% between 
2004 and 2014.” Before the 2013 “all-in” policy of 
the NRMP, data for the Residency Match did not 
accurately reflect the number of PGY-1 residents 
who actually entered training, because programs 
could fill positions (e.g., with IMGs) outside the 
Match. The Accreditation Council for Graduate 
Medical Education (ACGME) collects actual counts 
of residents occupying positions in accredited 
programs.3
Before “all-in,” the 2011 Match placed 23,420 
PGY-1 residents, and the ACGME counted 26,737 
entry-level residents in 2011–2012 (in “pipeline” 
programs leading to initial board certification). 
After “all-in,” the 2014 Match placed 26,678 PGY-1 
residents, and the ACGME counted 27,534 first-
year pipeline residents in 2014–2015, which is 
consistent with closer compliance with the “all-
in” policy. According to the ACMGE counts, the 
number of positions actually occupied by entry-
level pipeline residents increased from 24,069 in 
2004–2005 to 27,534 in 2014–2015, a 14.4% in-
crease.
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The authors reply: We appreciate the clarifica-
tion by Rockey et al. with regard to data from the 
ACGME. Although the magnitude of the increase 
in graduate medical education positions during 
the past decade is smaller than we indicated, our 
statement concerning the continued supply of 
residency positions for IMGs remains valid. Data 
from the 2015 Match indicate that there were 
1.51 positions per senior at U.S. allopathic medi-
cal schools, with IMGs (both U.S.-citizen and 
non–U.S.-citizen) filling 6301 of these excess 
positions,1 despite the increasing pool of seniors 
at U.S. allopathic medical schools and students 
and graduates of U.S. osteopathic medical schools.
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Human Infection with a Novel Avian Influenza A(H5N6) Virus
To the Editor: Multiple reassortant strains of 
novel, highly pathogenic avian influenza A(H5) 
viruses in clade 2.3.4.4 have recently emerged 
and spread in Asia, Europe, and North America, 
giving rise to multiple subtypes (H5N2, H5N5, 
H5N6, and H5N8).1-3 We report on a 59-year-old 
man in Guangzhou, China, with influenza 
A(H5N6) infection and associated illness. He had 
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a 30-year history of smoking and had stopped 
smoking in January 2014. He had undergone sur-
gery and chemotherapy for colon cancer, the last 
chemotherapy dose having been administered in 
April 2014. During the weeks before illness on-
set, he regularly purchased and handled live 
poultry in live poultry markets.
Fever and chills developed on December 3, 
2014. In the next 3 days, his body temperature 
rose to 40°C, and the fever was not relieved by 
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Figure 1. Timeline and Imaging.
Panel A is a timeline of the patient’s clinical course. Panels B and C show plain chest radiographs. Bilateral mild partial ground-glass 
opacities were observed in the lower lung, especially in the left lower lung field, on day 6 (Panel B) and extended to midlung fields by 
day 13 (Panel C). Panel D is a computed tomographic scan of the chest (lung window), showing bilateral ground-glass opacity and con-
solidation on day 14. ICU denotes intensive care unit.
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acetaminophen; vomiting, cough, and shortness 
of breath also developed. He was hospitalized on 
day 6 of his illness and began receiving anti-
biotic treatment (Fig. 1A). Chest radiography 
revealed mild bilateral ground-glass opacities in 
his lower lung (Fig. 1B). Two days later, pulse 
oximetry showed that the arterial blood oxygen 
saturation levels had declined (to approximately 
50 to 70%) in spite of the administration of high-
flow oxygen (5 to 6 liters per minute), and in-
vasive mechanical ventilation was commenced. 
A throat-swab sample was positive for influenza 
A virus, as assessed by means of real-time reverse-
transcriptase–polymerase chain reaction (PCR), 
and treatment with oseltamivir (150 mg twice a 
day for 13 days, administered through a naso-
gastric tube) was initiated on day 9. On day 12 of 
his illness, an influenza A virus isolate, desig-
nated A/Guangzhou/39715/2014 (H5N6), was ob-
tained from a throat-swab specimen (see the Sup-
plementary Appendix, available with the full text 
of this letter at NEJM.org, for details). Influenza 
A(H5N6) was identified by means of subtype-
specific PCR and sequencing of the virus isolate 
(GenBank accession numbers, KP765785 through 
KP765792).
On day 14, the patient was transferred to the 
isolation ward of the intensive care unit in the 
First Affiliated Hospital of Guangzhou Medical 
University. A chest radiograph and a computed 
tomographic scan showed progression of lung 
consolidation (Fig. 1C and 1D). Influenza A RNA 
was detectable by means of real-time PCR in spu-
tum samples but not from throat-swab, blood, 
urine, or stool samples. The next day, virus was 
undetectable in throat-swab, sputum, and bron-
choalveolar-fluid specimens. Multidrug-resistant 
Acinetobacter baumannii was detected in sputum but 
not in blood cultures. There was evidence of neu-
trophilia and lymphocytopenia (Table S1 in the 
Supplementary Appendix). Serum levels of aspar-
tate aminotransferase, creatinine, lactate dehy-
drogenase, creatine kinase, and myoglobulin were 
within the normal range throughout his illness. 
Antibiotic therapy was changed to teicoplanin, 
meropenem, and cefoperazone–sulbactam on 
day 18. Low-dose methylprednisolone treatment 
was started on day 21 and was administered 
until day 42. Imaging showed resolution of the 
bilateral lung infiltrations. Fever recurred on day 
25 in association with eosinophilia. Invasive 
mechanical ventilation was stopped on day 37, 
and the patient was later discharged (day 58). 
This case shows that a novel H5 clade 2.3.4.4 
influenza virus can cause human infection, 
similar to other influenza A(H5N1) viruses.4
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